Nanosphere Health Sciences Inc
NSHS
VERSES AI Inc
VERS
Kenadyr Metals Corp
KEN.H
Montauk Metals Inc
MTK
Montfort Capital Corp
MONT
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -694.59%-11.8M | -24.99%-4.11M | -1,733.87%-33.7M | 38.78%-30.2M | -23.74%-30.96M | 137.39%1.98M | 67.87%-3.29M | 123.52%2.06M | -791.86%-49.33M | -25.02M |
Net income from continuing operations | 40.46%-2.32M | -184.89%-3.24M | -14.19%-2.16M | -418.00%-12.5M | -580.01%-5.58M | -856.97%-3.89M | -180.84%-1.14M | -322.88%-1.89M | 61.02%3.93M | --1.16M |
Operating gains losses | 105.21%145.81K | -91.16%100.81K | -398.24%-264.96K | 22.77%-1.41M | -53.94%298.53K | -17.43%-2.8M | 253.50%1.14M | -108.20%-53.18K | -110.36%-1.83M | --648.14K |
Depreciation and amortization | -5.00%493.8K | 12.66%515.78K | -15.41%514.64K | 47.58%2.07M | 16.26%487.45K | -22.82%519.8K | 155.14%457.82K | 358.16%608.41K | 683.99%1.4M | --419.26K |
Asset impairment expenditure | ---- | ---- | ---- | --3.56M | --0 | ---- | ---- | ---- | --0 | --0 |
Remuneration paid in stock | 205.40%882.57K | 203.02%883.2K | -14.88%862.72K | 897.23%7.01M | 764.24%6.54M | -1,551.14%-837.37K | 244.79%291.47K | 616.22%1.01M | 1,131.84%703.18K | --757.28K |
Remuneration paid in stock | -46.34%137.27K | -48.66%168.5K | 34.29%276.53K | 80.34%1.09M | 34.43%303.99K | 42.46%255.82K | 218.22%328.23K | 110.64%205.93K | 305.32%606.61K | --226.13K |
Deferred tax | 10.26%-109.65K | 9.69%-109.65K | 20.14%-109.65K | -7.79%-667.88K | 58.80%-286.96K | -169.10%-122.2K | -209.62%-121.42K | -125.96%-137.31K | -29,479.37%-619.61K | ---696.47K |
Other non cashItems | -250.63%-11.87M | -76.05%395.07K | -1,608.10%-28.11M | 59.57%-18.57M | -2.77%-29.96M | 187.70%7.88M | 113.32%1.65M | 126.12%1.86M | -268.44%-45.94M | ---29.16M |
Change In working capital | 132.38%837.09K | 52.09%-2.83M | -1,142.11%-4.71M | -42.19%-10.79M | -270.38%-2.76M | 64.41%-2.59M | -608.41%-5.9M | 114.56%452.15K | -252.48%-7.59M | --1.62M |
-Change in receivables | 46.26%-1.34M | 39.96%-901.02K | -72.87%-4.12M | -283.76%-7.64M | -31.22%-1.27M | -173.62%-2.49M | -841.30%-1.5M | -649.91%-2.38M | -1,572.09%-1.99M | ---966.78K |
-Change in payables and accrued expense | 905.70%834.87K | 39.55%-1.99M | -111.17%-412.08K | 200.50%2.33M | 1,045.22%2.04M | -123.34%-103.62K | -444.78%-3.29M | 205.29%3.69M | -150.46%-2.32M | ---215.4K |
-Change in other current assets | 5,634.30%1.32M | -53.44%63.25K | 364.61%417.62K | -1,124.05%-2.21M | -2,863.24%-2.21M | --23K | --135.87K | -154.33%-157.82K | --215.87K | ---74.64K |
-Change in other current liabilities | 197.76%18.77K | --0 | 14.38%-595.57K | 16.78%-3.27M | 66.57%-1.32M | ---19.2K | ---1.24M | ---695.63K | -517.99%-3.94M | ---3.94M |
-Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%443.51K | --6.78M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -694.59%-11.8M | -24.99%-4.11M | -1,733.87%-33.7M | 38.78%-30.2M | -23.74%-30.96M | 137.39%1.98M | 67.87%-3.29M | 123.52%2.06M | -791.86%-49.33M | ---25.02M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -74.80%733.03K | 103.08%146.74K | 230.94K | 111.54%256.82K | 132.45%2.12M | -32.27%2.91M | -4.77M | 0 | -1,361.30%-2.23M | -6.52M |
Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -1,177.25%-1.9M | ---6.2M |
Net investment purchase and sale | -44.12%1.15M | ---- | ---- | ---2.42M | ---399K | --2.07M | ---- | ---- | --0 | --0 |
Dividends received (cash flow from investment activities) | -161.44%-421.44K | 121.39%146.74K | --274.7K | --2.57M | --2.57M | --685.93K | ---685.93K | --0 | --0 | --0 |
Net other investing changes | ---- | ---- | ---43.76K | 131.46%102.14K | ---55.15K | ---- | ---- | ---- | ---324.72K | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -74.80%733.03K | 103.08%146.74K | --230.94K | 111.54%256.82K | 132.45%2.12M | -32.27%2.91M | ---4.77M | --0 | -1,361.30%-2.23M | ---6.52M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 256.86%14.97M | -65.42%3.61M | 51,800.57%33.28M | -33.61%31.22M | -9.20%30.39M | -1,104.74%-9.54M | 16.35%10.43M | -101.77%-64.36K | 2,012.80%47.02M | 33.47M |
Net issuance payments of debt | 283.19%15.82M | -59.28%4.46M | 3,842.91%34.12M | -24.82%34.46M | -6.65%31.27M | -543.09%-8.64M | 25.20%10.96M | -47.15%865.35K | 31,814.23%45.84M | --33.5M |
Net common stock issuance | --0 | --0 | --0 | -100.25%-23.96K | -100.00%-63 | --0 | -100.00%-2 | -100.49%-23.89K | 25.10%9.41M | --1.85M |
Cash dividends paid | 6.09%-851.49K | -49.90%-854.03K | 10.46%-845.06K | 60.85%-3.3M | 54.74%-879.92K | 85.05%-906.74K | -171.66%-569.72K | -350.04%-943.82K | -20.33%-8.43M | ---1.94M |
Proceeds from stock option exercised by employees | --0 | --0 | --0 | -59.52%84.75K | --0 | --0 | -35.29%46.75K | -49.15%38K | -38.65%209.37K | --62.4K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 256.86%14.97M | -65.42%3.61M | 51,800.57%33.28M | -33.61%31.22M | -9.20%30.39M | -1,104.74%-9.54M | 16.35%10.43M | -101.77%-64.36K | 2,012.80%47.02M | --33.47M |
Net cash flow | ||||||||||
Beginning cash position | -31.88%7.75M | -10.47%8.06M | 18.16%8.28M | -24.76%7.01M | 23.50%6.74M | 230.04%11.38M | 139.01%9.01M | -24.76%7.01M | -27.64%9.31M | --5.45M |
Current changes in cash | 183.95%3.9M | -114.97%-355.83K | -109.61%-192.05K | 128.10%1.27M | -19.78%1.55M | -7,551.33%-4.65M | 287.80%2.38M | 138.91%2M | -44.87%-4.53M | --1.93M |
Effect of exchange rate changes | -1,201.00%-19.87K | 2,633.91%45.74K | ---25.86K | -100.05%-1.06K | 99.72%-1.06K | -99.91%1.81K | -100.19%-1.81K | --0 | 618.87%2.23M | ---373.71K |
End cash Position | 72.76%11.64M | -31.88%7.75M | -10.47%8.06M | 18.16%8.28M | 18.16%8.28M | 23.50%6.74M | 230.04%11.38M | 139.01%9.01M | -24.76%7.01M | --7.01M |
Free cash from | -694.59%-11.8M | -24.99%-4.11M | -1,733.87%-33.7M | 38.78%-30.2M | -23.74%-30.96M | 137.39%1.98M | 67.87%-3.29M | 123.52%2.06M | -791.86%-49.33M | ---25.02M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.